Scheer Partners Investments logo

Scheer Partners Investments

North America, Maryland, United States, Rockville

Description

Scheer Partners Investments is a company that offers investments and development services.

Investor Profile

Scheer Partners Investments has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Convertible Note, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Convertible Note (33%)
  • Series A (33%)
  • Series B (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Hardware
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Scheer Partners Investments frequently co-invest with?

Third Security
North America, Virginia, United States, Radford
Co-Investments: 1
Index Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 2
Advent International
North America, Massachusetts, United States, Boston
Co-Investments: 2
NC
North America, Virginia, United States, Radford
Co-Investments: 1

What are some of recent deals done by Scheer Partners Investments?

Aegerion Pharmaceuticals

Cambridge, Massachusetts, United States

Aegerion Pharmaceuticals engages in the development of therapeutics and pharmaceuticals to treat cardiovascular and metabolic diseases.

BiotechnologyHealth CareTherapeutics
Convertible NoteSep 18, 2008
Amount Raised: $3,764,043
Aegerion Pharmaceuticals

Cambridge, Massachusetts, United States

Aegerion Pharmaceuticals engages in the development of therapeutics and pharmaceuticals to treat cardiovascular and metabolic diseases.

BiotechnologyHealth CareTherapeutics
Series BNov 30, 2007
Amount Raised: $17,605,771
LevelVision

Roanoke, Virginia, United States

Video Display Technology

HardwareSoftware
Series ANov 2, 2006
Amount Raised: $5,000,000